Vascular Solutions Given New $21.00 Price Target at Feltl & Co. (VASC)
Equities researchers at Feltl & Co. boosted their price target on shares of Vascular Solutions (NASDAQ:VASC) from $18.75 to $21.00 in a research report issued on Wednesday, AnalystRatingsNetwork reports. The firm currently has a “buy” rating on the stock. Feltl & Co.’s price target suggests a potential upside of 12.36% from the stock’s previous close.
Shares of Vascular Solutions (NASDAQ:VASC) traded up 3.80% during mid-day trading on Wednesday, hitting $19.40. 62,174 shares of the company’s stock traded hands. Vascular Solutions has a 52 week low of $12.98 and a 52 week high of $17.37. The stock has a 50-day moving average of $16.30 and a 200-day moving average of $15.75. The company has a market cap of $325.7 million and a price-to-earnings ratio of 29.71.
Vascular Solutions (NASDAQ:VASC) last posted its quarterly earnings results on Tuesday, October 22nd. The company reported $0.19 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.07 by $0.12. The company had revenue of $28.01 million for the quarter, compared to the consensus estimate of $27.10 million. During the same quarter in the prior year, the company posted $0.16 earnings per share. The company’s quarterly revenue was up 14.1% on a year-over-year basis. Analysts expect that Vascular Solutions will post $0.68 EPS for the current fiscal year.
Vascular Solutions, Inc (NASDAQ:VASC) is a medical device company focused on providing clinically advanced solutions to interventional cardiologists and interventional radiologists.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.